Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients. - Wikidata - awgldk - TriplyDB

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.

http://www.wikidata.org/entity/Q33577482

about

HIV infection and older Americans: the public health perspective Evaluation of the utility of serum prolidase as a marker for liver fibrosis High Prevalence of Liver Fibrosis in Patients with Human Immunodeficiency Virus Monoinfection and Human Immunodeficiency Virus Hepatitis-B Co-infection as Assessed by Shear Wave Elastography: Study at a Teaching Hospital in Kenya Non-invasive markers for hepatic fibrosis Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus.Elevated aspartate aminotransferase-to-platelet ratio index in perinatally HIV-infected children in the United States X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4 Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children.Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients.The association of HIV viral load with indirect markers of liver injury.HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.Human immunodeficiency virus infection and the liver Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco.Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?Prevalence and predictors of elevated aspartate aminotransferase-to-platelet ratio index in Latin American perinatally HIV-infected children.Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals.A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.Liver involvement in human immunodeficiency virus infection.Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.Changing clinical profile and factors associated with liver enzyme abnormalities among HIV-infected persons.Liver fibrosis and fatty liver in Asian HIV-infected patients.Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry.HIV Infection and TLR Signalling in the Liver.Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic.HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.

P2860

Q26858824-B89FC71D-4DA3-445E-B83C-AF247C779D6D Q28239568-CA3FE1D0-D57A-46B0-90F8-12209BE4D849 Q30379450-E7CDC811-885D-40A0-922F-9FA31A7C8C0D Q30474093-9F13825D-463C-46B8-B803-93BAA2C92251 Q33621724-8CAC0CDA-005E-44A3-97EE-2CBD2ADEA056 Q34157971-14D1BCD9-1D25-414E-AD0D-6FE0C5ED0B73 Q34200171-EF905953-30C0-43F6-8913-7CB73665C64D Q34221539-AAF98F64-0955-4B1C-AEA2-453387CB3812 Q35619539-4A82BE85-344C-470B-A638-DF7D8B29C267 Q35628262-045F6D47-8C20-4165-9787-8A12C5E2A5CB Q35681714-BADA3FB5-6A7F-47F8-8C70-79BC543ACA70 Q35766031-D4995501-0CC0-4E87-B31E-F131FADCFA0D Q35772764-8B4921EF-7B55-47C5-9731-291947EA4570 Q35875848-A57973A3-155A-4B7B-9804-362DC3B30A72 Q36654566-FACEA20A-4FDA-4C14-A768-77C647A52BCC Q36671995-A9031B5E-DD84-4152-AF3F-F2493B7A9636 Q37013998-D8EB27A6-E675-4950-B951-31B23FA77B34 Q37266335-04F81422-8F9F-4CDE-91D6-A96AFFEAB331 Q37272320-75414CCA-3985-49D9-9BBE-DE3B421BAAA8 Q37305541-5C7D1242-70B5-49B3-87BE-1D75A9FE1AAC Q37328254-4A41EF14-184C-421B-BB21-9B8D29157ED7 Q37420263-151E484D-8CEF-4B8B-B68B-2585EE9A18F4 Q37585324-C6E2DFF2-F8D5-41E5-97BD-8DBE089C5151 Q38657651-42B9A021-4A54-46AF-B7B4-318DBAA6AB98 Q38852184-204ACE58-169B-477D-B570-F3D032A4470A Q39244103-77ED2D77-0228-4995-82DF-C68EC241A29C Q40488300-E28FA228-E9A9-436D-A2D8-52E7E9599FF8 Q40637208-19059882-5351-4DBF-86CE-19774963CD18 Q40701523-2D828BC1-2D43-4A5F-86C1-B5A2CF5ED40A Q40750320-BA81AD0E-879D-44D0-A796-C4F234916E01 Q41466494-3AE50BAD-AF94-4AF9-B952-9215CB3CBE26 Q41730093-075BCE21-2896-4195-A827-97D488A2D288 Q41814282-2AA1F786-D372-4D7C-AD80-DD51D0BBFBCD Q42199832-A8C953C0-876C-4A05-8E32-5C6071D1FBB2 Q42269060-8E9FCB0B-B973-4A48-9001-0D42DDD8AAF5 Q43677222-293FB471-636B-499A-AA86-5A2F2A8B2970 Q46142571-AE1A82C7-A907-4D1C-8CB8-7AD9A64FB853 Q47555238-D1D551A7-B24A-40EA-A916-190B994C14E4

P2860

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.

http://www.wikidata.org/entity/Q33577482

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@ast

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@en

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@nl

type

label

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@ast

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@en

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@nl

prefLabel

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@ast

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@en

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@nl

P1433

Q33577482-6DCC939A-A52E-46E0-9B05-69A0C26A5AD8

P1476

Q33577482-C9D1162C-3E2A-45EF-A5E0-585A8740A1CF

P2093

Q33577482-3CBD70DB-D241-4B39-A616-E92A730CC1FD

Q33577482-5F6944FE-F089-458B-8F13-A0F75D9A5542

Q33577482-689234E1-1592-46F2-934B-063679D3472C

Q33577482-869BA1F3-C2EF-4AD9-9388-774CA1A74FA7

Q33577482-E99B6E71-4888-4697-B814-79F4345783BE

P2860

Q33577482-0468D078-6D61-4052-AD26-45E53B648770

Q33577482-11C8B131-89C0-4FF2-83D2-B575F04BB4C6

Q33577482-12A055C8-CFB4-4046-8704-57F39B123A9E

Q33577482-14ECFAC9-EC6D-4C8E-9531-EB2E2DAF946C

Q33577482-17EE530B-6A1A-4D79-B46E-BA201286272B

Q33577482-241C1E6A-7F61-4831-8062-2B003033BE84

Q33577482-4B23AA04-6505-4CF4-A41F-8FE6B172F008

Q33577482-4B51B730-A171-43BE-A575-251CC842202F

Q33577482-50052FF2-3C96-4361-8F83-5555AA93BAAF

Q33577482-56F1C8DE-6481-498E-8620-223E6C7E3FD6

P2888

Q33577482-6A577A31-E1F5-44DF-BDDC-31B3413B0726

P304

Q33577482-CFB91A40-9A71-4625-BAE6-F055FA62DA3E

P31

Q33577482-B1B5055C-2593-4FDD-B63B-5384E51FD71A

P356

Q33577482-E7AA96FD-130F-4F32-8944-EDD15579445F

P478

Q33577482-DC94BE9B-4E9F-4651-8E96-0A0C594C31F1

P577

Q33577482-6E99AF75-16D1-4CC2-A5A7-275FD8327FC6

P5875

Q33577482-8C2F12C6-ABC2-481F-AD18-30F16DAC85AF

P6179

Q33577482-11889FE4-0BA5-4A53-B87D-33ED27B3B30B

P698

Q33577482-1E0048AD-67FA-404F-87F6-D9749941B1B2

P921

Q33577482-9E4A6D03-BEA8-452A-8284-5177CDB80B02

P932

Q33577482-48539F7F-EB83-49DF-887E-3E5FBD4156AA

P356

1471-2334-10-116

P1433

BMC Infectious Diseases

P1476

Prevalence and risk factors fo ...... ong HIV-monoinfected patients.

@en

P2093

Jay R Kostman

http://www.w3.org/2001/XMLSchema#string

Michelle DallaPiazza

http://www.w3.org/2001/XMLSchema#string

Russell Localio

http://www.w3.org/2001/XMLSchema#string

Valerianna K Amorosa

http://www.w3.org/2001/XMLSchema#string

Vincent Lo Re

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ count-guided interruption of antiretroviral treatment

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.

Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.

Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.

P2888

1471-2334-10-116

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-10-116

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44595317

http://www.w3.org/2001/XMLSchema#string

P6179

1028370359

http://www.w3.org/2001/XMLSchema#string

P698

20465840

http://www.w3.org/2001/XMLSchema#string

P921

P932

2876168

http://www.w3.org/2001/XMLSchema#string